Expanded Indication for a First-in-Class Oral Therapy for the Treatment of Metastatic Breast Cancer

An Informational Program
Featuring
LINDA BUCK, NP

Expanded Indication for a First-in-Class Oral Therapy for the Treatment of a Broad Range of Women With HR+/HER2- Metastatic Breast Cancer

Registration:
http://pfizerengagementportal.force.com/Invitation/ahm__CCRegistrationHome?uc=YTEyMzYwMDAwMEFnTTAwQUFG